Middle East & Africa Virtual Masterclass
Course Overview
The IPC Psoriasis Masterclass is designed for dermatologists who are making treatment decisions and managing patients with psoriasis and are interested in specializing in psoriasis.
Over the five days of the course, IPC’s world-renowned experts will cover a variety of topics including the pathogenesis of psoriasis, new and emerging therapies and how to be an advocate for your patient.
The Masterclass agenda has been carefully developed to provide knowledge for daily use to the practicing dermatologist in an intimate environment designed to maximize faculty/participant interactions. Through lectures, panels, case-based discussions and question-answer sessions, attendees will obtain practical and important information for their dermatology practice.
The IPC Masterclass is open to dermatologists and general practitioners who meet the following criteria:
- A diploma, 1st part MSc or higher degree in internal medicine or dermatology
- Practicing internal medicine or dermatology within a governmental establishment i.e. university hospital, public hospitals, rural hospitals, etc.
- At least 3 years of practice
There is no cost to attend the program, but space is limited. The application deadline is January 9, 2022.
Timezones:
Morocco/Nigeria/Tunisia Time: 12:00 – 2:00 pm
Cairo/Lebanon/South Africa Time: 1:00 – 3:00 pm
Ethiopia/Iraq/Kenya/Saudi Arabia Time: 2:00 – 4:00 pm
United Arab Emirates Time: 3:00 – 5:00 pm
Agendas
Session 1 – January 27
Epidemiology, Pathogenesis, and Disease Spectrum
WELCOME + INTRODUCTION
Mahira Hamdy El Sayed
The Global Psoriasis Atlas: Epidemiology and Access
Chris Griffiths
Pathogenesis: Bench to Bedside
Peter van de Kerkhof
Psoriasis in Limited Resource Regions
Angela Londoño
Audience Q & A
Faculty
Clinical Case: Erythroderma
Priscilla Angwenyi
Pustular Psoriasis
Mahira Hamdy El Sayed
Challenging Case: Pustular Psoriasis
Mona El-Kalioby
CLOSING COMMENTS
Mohamed El-Komy
Session 2 – February 3
Disease Assessment and Treatment Modalities
WELCOME + INTRODUCTION
Mohamed El-Komy
IPC Disease Severity Classification
Lone Skov
How to Treat Patients with Mild Disease
Peter van de Kerkhof
WHAT TO DO WHEN TOPICALS ARE NOT APPROPRIATE ANYMORE
Phototherapy
Mahmoud Abdallah
Conventional Systemics Including Pipeline
Mohamed El-Komy
Biologics & Biosimilars
Mahira Hamdy El Sayed
Audience Q & A
Faculty
CLOSING COMMENTS
Mahira Hamdy El Sayed
Session 3 – February 10
Psoriasis as a Systemic Disease
WELCOME + INTRODUCTION
Mahira Hamdy El Sayed
Psoriasis as a Systemic Disease
Mahira Hamdy El Sayed
Psoriasis Management with HIV and Other Viral Conditions
Gail Todd
Audience Q & A
Faculty
Psoriatic Arthritis
Reem Hamdy
Psoriasis and the Gut
Audience Q & A
Faculty
CLOSING COMMENTS
Mohamed El-Komy
Session 4 – February 17
Specific Areas and Specific Situations
WELCOME + INTRODUCTION
Mohamed El-Komy
Psoriasis in Women and Children
Mahira Hamdy El Sayed
Geriatric Psoriasis
Peter van de Kerkhof
Difficult to Treat Areas
Andreas Pinter
Psoriasis Symptoms
Paolo Gisondi
Audience Q & A
Faculty
CLOSING COMMENTS
Mahira Hamdy El Sayed
Session 5 – February 24
WELCOME + INTRODUCTION
Mahira Hamdy El Sayed
Challenging Cases by Attendees
Nejib Doss, Moderator
Personalized Medicine
Chris Griffiths
The Future of Psoriasis
Peter van de Kerkhof
KEY LEARNINGS AND PROGRAM CLOSING
Mahira Hamdy El Sayed and Mohamed El-Komy
Program Co-Chairs
Faculty
Mona El-Kalioby, MBBCh, MSc, MD
Cairo University Kasr Al-Ainy School of Medicine and Kasr Al-Ainy Hospital
Cairo, Egypt
Bio
Christopher Griffiths, OBE, MD, FRCP, FMedSci
University of Manchester
Manchester, United Kingdom
Honorary Founder
Bio
Lone Skov, MD, PhD
Herlev and Gentofte Hospital, University of Copenhagen
Hellerup, Denmark
IPC Board Member
Bio
Program Sponsors
